Trident Texofab schedules AGM for September 30 to approve FY26 results
- Trident Texofab scheduled its 18th AGM for September 30, 2026, to approve FY26 results
- Remote e-voting opens on September 27 and closes on September 29, 2026
- Board recommends reappointment of director Manish Halwawala who retires by rotation
- Shareholders to approve related party transactions up to ₹25 crore with group entities
*this image is generated using AI for illustrative purposes only.
Trident Texofab approved its financial results for FY26 and scheduled its 18th annual general meeting during a board session on September 7, 2026. The company confirmed that the AGM will take place on September 30, 2026, at 4:00 pm via video conferencing or other audio-visual means.
The register of members and share transfer books will remain closed from September 24 to September 30, 2026, inclusive. The cut-off date for remote e-voting is set for September 23, 2026. The remote e-voting period commences on Sunday, September 27, 2026 at 9:00 am and ends on Tuesday, September 29, 2026 at 5:00 pm.
Key Board Resolutions
The board recommended the reappointment of Mr. Manish Dhirajlal Halwawala, who retires by rotation. His appointment is subject to shareholder approval at the upcoming AGM. The board also appointed CS Mebul Amareliya as the scrutinizer for the e-voting process.
The AGM agenda includes special business items such as approving related party transactions for FY27 with entities including Trident Lifeline Limited and Trident Mediquip Limited, up to a maximum aggregate value of ₹25 crore each. Additionally, shareholders are asked to approve the payment of managerial remuneration in excess of limits prescribed under the Companies Act, 2013, for directors Hardik Jigishkumar Desai, Chetan Chandrakant Jariwala, and Manish Dhirajlal Halwawala.
Cost Auditor Appointment
On the recommendation of the Audit Committee, the board appointed M/s. PAAA & Associates as the cost auditor for FY27. The firm holds registration number 006283 and will conduct the audit of cost records in accordance with Section 148 of the Companies Act, 2013. The remuneration for this appointment is set at ₹35,000 plus applicable taxes.
| Particular | Details |
|---|---|
| Auditor Name | M/s. PAAA & Associates |
| Appointment Date | September 7, 2026 |
| Term | Financial Year 2026-2027 |
| Relationship Disclosure | NIL |
Source: https://lodr-files.dhan.co/lodr-inputs/Company/INE071Y01013/aa98e2ca-4035-40e4-a318-f03544abb608.pdf
Historical Stock Returns for Trident Texofab
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +3.51% | +0.48% | -10.06% | -56.13% | -93.82% | -47.90% |
How might the approval of related party transactions totaling up to ₹50 crore with Trident Lifeline and Trident Mediquip impact Trident Texofab's operational costs or profit margins in FY27?
What are the specific performance metrics or strategic initiatives that justify the proposed managerial remuneration exceeding statutory limits for the three named directors?
Will the reappointment of Mr. Manish Dhirajlal Halwala signal continuity in current management strategy, or are investors expecting new leadership directions post-AGM?
17
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
